Regeneron Pharmaceuticals, Inc. Stock Performance
as on November 15, 2025 at 2:29 am IST
Day's Low
Day's High
$685.95$699.27
1.05%
Downside
0.87%
Upside
52 Week's Low
52 Week's High
$476.49$803.4231.27%
Downside
15.89%
Upside
Regeneron Pharmaceuticals, Inc. share price movements today
- Previous Close
- $694.99
- Open
- $692.84
- Volume
- 627.9K
- Day's Low - High
- $685.95 - $699.27
- 52 Week Low - High
- $476.49 - $803.42
Regeneron Pharmaceuticals, Inc. Historical Returns
- 1 Month Return
- + 21.37 %
- 3 Month Return
- + 22.8 %
- 1 Year Return
- -11.18 %
- 3 Year Return
- -6.34 %
- 5 Year Return
- + 22.7 %
Regeneron Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Check Regeneron Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$71.6B
EPS (TTM)
43.225
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.18%
PE Ratio (TTM)
16.34
Industry PE ratio
19.200384615384614
PEG Ratio
1.3405
EBITDA
4.3B
Revenue (TTM)
14.2B
Profit Margin
32.13%
Return On Equity TTM
15.19%
Regeneron Pharmaceuticals, Inc. Stock Valuation
Track how Regeneron Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Regeneron Pharmaceuticals, Inc. in the last 5 years
Lowest (8.61x)
December 31, 2021
Today (16.34x)
November 14, 2025
Industry (19.20x)
November 14, 2025
Highest (24.50x)
September 30, 2024
Today’s Price to Earnings Ratio: 16.34x
Regeneron Pharmaceuticals, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Regeneron Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $71.6B | 22.7% | 16.34 | 32.13% | |
| BUY | $59.8B | 235.01% | 1414.81 | 1.36% | |
| NA | $40.9B | NA | 712.21 | 1.38% | |
| BUY | $110.2B | 92.67% | 30.58 | 31.35% |
Stock Returns calculator for Regeneron Pharmaceuticals, Inc. Stock including INR - Dollar returns
The Regeneron Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Regeneron Pharmaceuticals, Inc. investment value today
Current value as on today
₹93,788
Returns
Returns from Regeneron Pharmaceuticals, Inc. Stock
Dollar Returns*
₹5,194 (+5.19%)
Analyst Recommendation on Regeneron Pharmaceuticals, Inc. Stock
Based on 34 analysts
76.47%
Buy
20.59%
Hold
2.94%
Sell
Based on 34 analysts, 76.47% of analysts recommend a 'BUY' rating for Regeneron Pharmaceuticals, Inc.. Average target price of $753.17
Regeneron Pharmaceuticals, Inc. Share Price Target
Get share price movements and forecasts by analysts on Regeneron Pharmaceuticals, Inc..
What analysts predicted
7.96%UPSIDE
Target Price
$753.17
Current Price
$693.25
Analyzed by
34 Analysts
Target
$753.17
Regeneron Pharmaceuticals, Inc. target price $753.17, a slight upside of 7.96% compared to current price of $693.25. According to 34 analysts rating.
Regeneron Pharmaceuticals, Inc. Stock’s Investor Sentiment and Interest
Investment in Regeneron Pharmaceuticals, Inc. Shares on INDmoney has dropped by -41.35% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Regeneron Pharmaceuticals, Inc. Stock has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Regeneron Pharmaceuticals, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Regeneron Pharmaceuticals, Inc. Annual Profit & Loss
All numbers in Millions USD
Regeneron Pharmaceuticals, Inc. Quarterly Cash Flow
All numbers in Millions USD
Regeneron Pharmaceuticals, Inc. Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Regeneron Pharmaceuticals, Inc. Stock
Check out the Mutual Funds with significant holdings in Regeneron Pharmaceuticals, Inc..
Funds | Holdings | Shares Held |
|---|---|---|
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.11359% | 804 |
 Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | 0.51236% | 167 |
 ICICI Prudential NASDAQ 100 Index Fund Direct Growth | 0.3138% | 1599 |
Global Institutional Holdings in Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. News & Key Events
Today's Timeline - 13 November
Thu, 05:51 PM
-Regeneron announces updated data from hematology pipeline to be presented at ASH 2025 Annual Meeting in December.
Thu, 09:29 PM
-FDA to decide on Regeneron's Eylea HD approval application by November 30th, targeting eye diseases.
Insights on Regeneron Pharmaceuticals, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Regeneron Pharmaceuticals, Inc. has shown a strong upward trend in its net profit over the last three quarters. The net profit increased from $808.7 million to $1.46 billion, marking an average quarterly growth of 23.3%. This consistent growth indicates a positive financial performance for the company.
- POSITIVE IMPACT
Revenue Rich
Regeneron Pharmaceuticals, Inc. has seen positive revenue growth over the last three quarters. Their revenue increased from $3.02 billion to $3.75 billion, showing an average quarterly growth rate of 9.9%.
- POSITIVE IMPACT
Price Rise
In the last 1 month, REGN stock has moved up by 20.6%
NO EFFECTAgainst Peers
In the last 1 year, Beone Medicines Ltd has given 94.7% return, outperforming this stock by 102.9%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 77.3% return, outperforming this stock by 81.9%
About Regeneron Pharmaceuticals, Inc.
| Organisation | Regeneron Pharmaceuticals, Inc. |
| Headquarters | 777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707 |
| Industry | Health Technology |
| CEO | Dr. Leonard S. Schleifer M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Regeneron Pharmaceuticals, Inc.
Name | Title |
|---|---|
Mr. Bob McCowan | Senior VP of IT & Chief Information Officer |
Dr. Leonard S. Schleifer M.D., Ph.D. | Co-Founder, President, CEO & Co-Chairman |
Mr. Christopher R. Fenimore CPA | Executive VP of Finance & CFO |
Dr. Andrew J. Murphy Ph.D. | Executive VP of Research & Co-Chief Scientific Officer |
Mr. Daniel P. Van Plew | Executive VP and GM of Industrial Operations & Product Supply |
Mr. Rajesh Ahuja | Senior Vice President of Quality Assurance & Operations |
Mr. Ryan Crowe | Senior Vice President of Investor Relations & Strategic Analysis |
Mr. Joseph J. LaRosa J.D. | Executive VP, General Counsel & Secretary |
Ms. Melissa Lozner | Senior VP & Chief Compliance Officer |
Dr. George D. Yancopoulos M.D., Ph.D. | Co-Founder, President, Chief Scientific Officer & Co-Chairman |
FAQs
What is Regeneron Pharmaceuticals, Inc. share price today?
Regeneron Pharmaceuticals, Inc. share price today is $693.25 as on at the close of the market. Regeneron Pharmaceuticals, Inc. share today touched a day high of $699.27 and a low of $685.95.
What is the 52 week high and 52 week low for Regeneron Pharmaceuticals, Inc. share?
Regeneron Pharmaceuticals, Inc. share touched a 52 week high of $803.42 on and a 52 week low of $476.49 on . Regeneron Pharmaceuticals, Inc. stock price today i.e. is closed at $693.25,which is 13.71% down from its 52 week high and 45.49% up from its 52 week low.
What is Regeneron Pharmaceuticals, Inc.'s market capitalisation today?
Regeneron Pharmaceuticals, Inc. market capitalisation is $0.07T as on .
How to invest in Regeneron Pharmaceuticals, Inc. Stock (REGN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Regeneron Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Regeneron Pharmaceuticals, Inc. Shares that will get you 0.0022 shares as per Regeneron Pharmaceuticals, Inc. share price of $693.25 per share as on November 15, 2025 at 2:29 am IST.
What is the minimum amount required to buy Regeneron Pharmaceuticals, Inc. Stock (REGN) from India?
Indian investors can start investing in Regeneron Pharmaceuticals, Inc. (REGN) shares with as little as ₹88.7 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.00 in Regeneron Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Regeneron Pharmaceuticals, Inc. share’s latest price of $693.25 as on November 15, 2025 at 2:29 am IST, you will get 0.0144 shares of Regeneron Pharmaceuticals, Inc.. Learn more about
fractional shares .
What are the returns that Regeneron Pharmaceuticals, Inc. has given to Indian investors in the last 5 years?
Regeneron Pharmaceuticals, Inc. stock has given 22.7% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?